Avanos reports Q3 adjusted EPS 30c, consensus 28c

Reports Q3 revenue $171.3M, consensus $169.6M. “We are pleased with our results for this quarter as we continue to deliver above-market growth in our Digestive Health markets,” said Joe Woody, Avanos’s chief executive officer. Woody continued, “We believe we are poised to sustain the momentum in Digestive Health and we are also confident that our strategy for the Pain Management and Recovery business will lead to sustainable growth as we enter 2024.”